Sequelae or persistent symptoms (SPS) | Total (n = 797) | Men (n = 428) | Women (n = 369) | P-value |
---|---|---|---|---|
N (%), x (s) | N (%), x (s) | N (%), x (s) | ||
Any SPS | 509 (63.9) | 267 (62.4) | 242 (65.6) | 0.348 |
Any systemic/general SPS | 288 (36.1) | 140 (32.7) | 148 (40.1) | 0.030* |
Persistent fever | 56 (7.0) | 28 (6.5) | 28 (7.6) | 0.565 |
Fatigue | 176 (22.1) | 81 (18.9) | 95 (25.7) | 0.021* |
Muscle weakness | 30 (3.8) | 20 (4.7) | 10 (2.7) | 0.147 |
Musculoskeletal pain | 122 (15.3) | 53 (12.4) | 69 (18.7) | 0.014* |
General malaise | 34 (4.3) | 18 (4.2) | 16 (4.3) | 0.928 |
Oedema | 23 (2.9) | 12 (2.8) | 11 (3.0) | 0.881 |
Pressure ulcers | 14 (1.8) | 6 (1.4) | 8 (2.2) | 0.412 |
Any respiratory SPS | 335 (42.0) | 183 (42.8) | 152 (41.2) | 0.655 |
Dyspnoea | 223 (28.0) | 128 (29.9) | 95 (25.7) | 0.192 |
Rib pain | 36 (4.5) | 17 (4.0) | 19 (5.1) | 0.425 |
Thoracic pain | 53 (6.6) | 28 (6.5) | 25 (6.8) | 0.895 |
Persistent cough | 153 (19.2) | 77 (20.9) | 76 (17.8) | 0.266 |
Persistent pharyngeal symptoms | 67 (8.4) | 33 (7.7) | 34 (9.2) | 0.446 |
Any neurological SPS | 166 (20.8) | 84 (19.6) | 82 (22.2) | 0.368 |
ICU-related polyneuropathya | 25 (3.1) | 16 (3.7) | 9 (2.4) | 0.294 |
Headache | 42 (5.3) | 14 (3.3) | 28 (7.6) | 0.007* |
Paraesthesia | 27 (3.4) | 18 (4.2) | 9 (2.4) | 0.169 |
Movement disturbances | 27 (3.4) | 13 (3.0) | 14 (3.8) | 0.556 |
Disorientation or confusion | 21 (2.6) | 11 (2.6) | 10 (2.7) | 0.902 |
Persistent anosmia or dysgeusia | 57 (7.2) | 30 (7.0) | 27 (7.3) | 0.987 |
Any mental health SPS | 97 (12.2) | 39 (9.1) | 58 (15.7) | 0.004* |
Depressive symptoms | 35 (4.4) | 11 (2.6) | 24 (6.5) | 0.007* |
Anxiety symptoms | 54 (6.8) | 18 (4.2) | 36 (9.8) | 0.002* |
Sleep disturbances | 39 (4.9) | 22 (5.1) | 17 (4.6) | 0.728 |
Any haematological SPS | 35 (4.4) | 15 (3.5) | 20 (5.4) | 0.188 |
Thrombotic manifestations | 25 (3.1) | 9 (2.1) | 16 (4.3) | 0.071 |
Any dermatological SPS | 74 (9.3) | 34 (7.9) | 40 (10.8) | 0.160 |
Pruritus | 20 (2.5) | 11 (2.6) | 9 (2.4) | 0.906 |
Alopecia | 24 (3.0) | 1 (0.2) | 23 (6.2) | <0.001* |
Exanthema | 25 (3.1) | 17 (4.0) | 8 (2.2) | 0.145 |
Eczema | 12 (1.5) | 8 (1.9) | 4 (1.1) | 0.364 |
Any nephrological SPS | 36 (4.5) | 18 (4.2) | 18 (4.9) | 0.649 |
Renal insufficiency de novo | 7 (0.9) | 4 (0.9) | 3 (0.8) | 0.854 |
Any urological SPS | 34 (4.3) | 21 (4.9) | 13 (3.4) | 0.335 |
Any endocrinological SPS | 12 (1.5) | 10 (2.3) | 2 (0.5) | 0.038* |
Glycaemia uncontrol | 7 (0.9) | 6 (1.4) | 1 (0.3) | 0.088 |
Any otorhinolaryngological SPS | 25 (3.1) | 8 (1.9) | 17 (4.6) | 0.027* |
Vertigo symptoms | 15 (1.9) | 3 (0.7) | 12 (3.3) | 0.008* |
Otoacoustic symptoms | 10 (1.3) | 4 (0.9) | 6 (1.6) | 0.382 |
Ophthalmological SPS | 37 (4.6) | 16 (3.7) | 21 (5.7) | 0.191 |
Digestive symptoms | 129 (26.2) | 63 (14.7) | 66 (17.9) | 0.226 |
Diarrhoea | 82 (10.3) | 35 (8.2) | 47 (12.7) | 0.035* |
Constipation | 14 (1.8) | 7 (1.6) | 7 (1.9) | 0.779 |
Vomiting | 16 (2.0) | 3 (0.7) | 13 (3.5) | 0.005* |
Abdominal pain | 43 (5.4) | 20 (4.7) | 23 (6.2) | 0.331 |
Anorexia | 8 (1.0) | 4 (0.9) | 4 (1.1) | 0.833 |
Cardiovascular SPS | 46 (5.8) | 26 (6.1) | 20 (5.4) | 0.693 |
Hypotension or syncope | 23 (2.9) | 14 (3.3) | 9 (2.4) | 0.484 |
Arrythmia or palpitations | 25 (3.1) | 13 (3.0) | 12 (3.3) | 0.862 |
Superinfection | 63 (7.9) | 30 (7.0) | 33 (8.9) | 0.313 |
Urinary tract infection | 31 (3.9) | 15 (3.5) | 16 (4.3) | 0.545 |
Pneumonia | 6 (0.8) | 4 (0.9) | 2 (0.5) | 0.691 |
Mycosis | 11 (1.4) | 6 (1.4) | 5 (1.4) | 0.955 |
Return to Emergency Services | 160 (20.3) | 85 (20.0) | 75 (20.7) | 0.818 |
Readmission to hospitalb | 35 (12.1) | 15 (9.9) | 20 (14.5) | 0.227 |
Death after discharge | 8 (1.0) | 3 (0.7) | 5 (1.4) | 0.356 |
Total | 797 (100) | 428 (53.7) | 369 (46.3) | – |